Human Longevity, Inc. Hires Sally A. Howard as Head of Regulatory Affairs and Policy
(SAN DIEGO, CA) November 4, 2015—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, anno...
Human Longevity, Inc. and Venter Institute Scientists Publish Paper Demonstrating Inconsistency in Microbiome Studies due to Variable Approaches to DNA Sequencing and Data Analysis
Comparison of four common library prep methods found significant differences in types of microbes uncovered and sho...
Human Longevity, Inc. Launches the Health Nucleus, a Comprehensive and Personalized Health Platform for Individuals
(SAN DIEGO, CA) OCTOBER 13, 2015 – Human Longevity, Inc. (HLI), the genomics-based, technology-driven company wor...
Human Longevity, Inc. Appoints William A. Roper, Jr. as Chief Financial Officer
(SAN DIEGO, CA) September 28, 2015—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, an...
- RT @CBinsights: Game Changers: 55 startups that prove innovation is alive and well https://t.co/UmCyjqOuuR @humanlongevity https://t.co/36X…
[2 weeks ago]
- RT @BGood_Media: Great video @humanlongevity “Geneticist Craig Venter helped sequence the human genome. Now he wants yours” https://t.co/Ls…
[3 weeks ago]
- .@HumanLongevity Hires Sally A. Howard as Head of Regulatory Affairs and Policy https://t.co/JuiHh2LFNH
[3 weeks ago]
Using the combined power of our core areas of expertise—genomics, informatics, and stem cell therapies, we are tackling one of the greatest medical/scientific and societal challenges—aging and aging related diseases. –Dr. J. Craig Venter
The global market for healthy human longevity is enormous with total healthcare expenditures in those 65 and older running well over $7 trillion. We believe that HLI’s unique science and technology, along with our business leadership, will positively impact the healthcare market with novel diagnostics and therapeutics. –Dr. Robert Hariri
HLI is going to change the way medicine is practiced by helping to shift to a more preventive, genomic-based medicine model which we believe will lower healthcare costs. Our goal is not necessarily lengthening life, but extending a healthier, high performing, more productive life span. –Dr. J. Craig Venter
Between 1910 and 2010 improvements in medicine and sanitation increased the human lifespan by 50 percent from 50 to 75 years. Today with the emergence of exponential technologies such as those being pioneered and advanced by HLI we have the potential to meaningfully extend the lifespan even further. –Dr. Peter H. Diamandis